{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:57:35Z","timestamp":1791280655536,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/jhh.2015.38","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T05:21:47Z","timestamp":1430976107000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic"],"prefix":"10.1038","volume":"30","author":[{"given":"M A","family":"Hameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tebbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"issue":"5","key":"BFjhh201538_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJL Murray","year":"2013","unstructured":"Murray CJL, Lopez AD . Measuring the global burden of disease. N Engl J Med 2013; 369 (5): 448\u2013457.","journal-title":"N Engl J Med"},{"issue":"7","key":"BFjhh201538_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (7): 1281\u20131357.","journal-title":"J Hypertens"},{"key":"BFjhh201538_CR3","unstructured":"National Institute for Health and Clinical Excellence Hypertension: Clinical Management of Primary Hypertension in Adults. National Institute for Health and Clinical Excellence London, UK, 2011."},{"issue":"5","key":"BFjhh201538_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","volume":"57","author":"A de la Sierra","year":"2011","unstructured":"de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57 (5): 898\u2013902.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201538_CR5","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","volume":"57","author":"SD Persell","year":"2011","unstructured":"Persell SD . Prevalence of resistant hypertension in the United States, 2003\u20132008. Hypertension 2011; 57 (6): 1076\u20131080.","journal-title":"Hypertension"},{"issue":"9","key":"BFjhh201538_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","volume":"124","author":"BM Egan","year":"2011","unstructured":"Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC . Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011; 124 (9): 1046\u20131058.","journal-title":"Circulation"},{"issue":"4","key":"BFjhh201538_CR7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"VL Roger","year":"2011","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association. Circulation 2011; 123 (4): e18\u2013e209.","journal-title":"Circulation"},{"issue":"13","key":"BFjhh201538_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","volume":"125","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125 (13): 1635\u20131642.","journal-title":"Circulation"},{"issue":"21","key":"BFjhh201538_CR9","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1001\/archinte.168.21.2340","volume":"168","author":"GF Salles","year":"2008","unstructured":"Salles GF, Cardoso CL, Muxfeldt ES . Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Int Med 2008; 168 (21): 2340\u20132346.","journal-title":"Arch Int Med"},{"issue":"7","key":"BFjhh201538_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1751-7176.2009.00138.x","volume":"11","author":"WJ Elliott","year":"2009","unstructured":"Elliott WJ . Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens 2009; 11 (7): 376\u2013382.","journal-title":"J Clin Hypertens"},{"issue":"11","key":"BFjhh201538_CR11","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/01.hjh.0000186832.41125.8a","volume":"23","author":"G Mazzaglia","year":"2005","unstructured":"Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifiro G, Cricelli C et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23 (11): 2093\u20132100.","journal-title":"J Hypertens"},{"issue":"11","key":"BFjhh201538_CR12","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1097\/01.hjh.0000187261.40190.2e","volume":"23","author":"BL Van Wijk","year":"2005","unstructured":"Van Wijk BL, Klungel OH, Heerdink ER, de Boer A . Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23 (11): 2101\u20132107.","journal-title":"J Hypertens"},{"issue":"3","key":"BFjhh201538_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00149831-200506000-00010","volume":"12","author":"EC Yiannakopoulou","year":"2005","unstructured":"Yiannakopoulou EC, Papadopulos JS, Cokkinos DV, Mountokalakis TD . Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005; 12 (3): 243\u2013249.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"12","key":"BFjhh201538_CR14","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1345\/aph.1Q523","volume":"45","author":"RJ Romanelli","year":"2011","unstructured":"Romanelli RJ, Schiro TA, Jukes T, Wong KS, Ishisaka DY . Disparities in blood pressure control within a community-based provider network: an exploratory analysis. Ann Pharmacother 2011; 45 (12): 1473\u20131482.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"BFjhh201538_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42 (3): 200\u2013209.","journal-title":"Med Care"},{"issue":"2","key":"BFjhh201538_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/HJH.0000000000000382","volume":"33","author":"M Krousel-Wood","year":"2015","unstructured":"Krousel-Wood M, Holt E, Joyce C, Ruiz R, Dornelles A, Webber LS et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). J Hypertens 2015; 33 (2): 412\u2013420.","journal-title":"J Hypertens"},{"issue":"4","key":"BFjhh201538_CR17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","volume":"31","author":"O Jung","year":"2013","unstructured":"Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013; 31 (4): 766\u2013774.","journal-title":"J Hypertens"},{"issue":"2","key":"BFjhh201538_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.113.00687","volume":"62","author":"M Burnier","year":"2013","unstructured":"Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J . Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension 2013; 62 (2): 218\u2013225.","journal-title":"Hypertension"},{"issue":"8","key":"BFjhh201538_CR19","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/HJH.0b013e32832d50ef","volume":"27","author":"A Christensen","year":"2009","unstructured":"Christensen A, Osterberg LG, Hansen EH . Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens 2009; 27 (8): 1540\u20131551.","journal-title":"J Hypertens"},{"issue":"1","key":"BFjhh201538_CR20","doi-asserted-by":"publisher","first-page":"e53373","DOI":"10.1371\/journal.pone.0053373","volume":"8","author":"R Belknap","year":"2013","unstructured":"Belknap R, Weis S, Brookens A, Au-Yeung KY, Moon G, DiCarlo L et al. Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy. PLoS ONE 2013; 8 (1): e53373.","journal-title":"PLoS ONE"},{"issue":"9","key":"BFjhh201538_CR21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5694\/j.1326-5377.2006.tb00662.x","volume":"185","author":"MR Nelson","year":"2006","unstructured":"Nelson MR, Reid CM, Ryan P, Willson K, Yelland L . Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006; 185 (9): 487\u2013489.","journal-title":"Med J Aust"},{"issue":"1","key":"BFjhh201538_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","volume":"40","author":"F Kettani","year":"2009","unstructured":"Kettani F, Dragomir A, C\u00f4t\u00e9 R, Roy L, B\u00e9rard A, Blais L et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40 (1): 213\u2013220.","journal-title":"Stroke"},{"issue":"16","key":"BFjhh201538_CR23","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120 (16): 1598\u20131605.","journal-title":"Circulation"},{"issue":"6","key":"BFjhh201538_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11606-009-1240-1","volume":"25","author":"JE Bailey","year":"2010","unstructured":"Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC . Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Int Med 2010; 25 (6): 495\u2013503.","journal-title":"J Gen Int Med"},{"issue":"3","key":"BFjhh201538_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","volume":"29","author":"G Corrao","year":"2011","unstructured":"Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011; 29 (3): 610\u2013618.","journal-title":"J Hypertens"},{"key":"BFjhh201538_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/CEOR.S15619","volume":"3","author":"LD Esposti","year":"2011","unstructured":"Esposti LD, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. ClinicoEconomics Outcomes Res 2011; 3: 47\u201354.","journal-title":"ClinicoEconomics Outcomes Res"},{"issue":"38","key":"BFjhh201538_CR27","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","volume":"34","author":"R Chowdhury","year":"2013","unstructured":"Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013; 34 (38): 2940\u20132948.","journal-title":"Eur Heart J"},{"issue":"2","key":"BFjhh201538_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00004872-200102000-00022","volume":"19","author":"M Burnier","year":"2001","unstructured":"Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR . Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19 (2): 335\u2013341.","journal-title":"J Hypertens"},{"issue":"1","key":"BFjhh201538_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1742-1241.1999.tb11657.x","volume":"53","author":"B Waeber","year":"1999","unstructured":"Waeber B, Vetter W, Darioli R, Keller U, Brunner HR . Improved blood pressure control by monitoring compliance with antihypertensive therapy. Int J Clin Pract 1999; 53 (1): 37\u201338.","journal-title":"Int J Clin Pract"},{"issue":"2","key":"BFjhh201538_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004872-199102000-00003","volume":"9","author":"S Trazzi","year":"1991","unstructured":"Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G . Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991; 9 (2): 115\u2013119.","journal-title":"J Hypertens"},{"issue":"5","key":"BFjhh201538_CR31","first-page":"569","volume":"34","author":"LM Prisant","year":"1992","unstructured":"Prisant LM, Carr AA, Bottini PB, Thompson WO, Rhoades RB . Repeatability of automated ambulatory blood pressure measurements. J Fam Pract 1992; 34 (5): 569\u2013574.","journal-title":"J Fam Pract"},{"issue":"9290","key":"BFjhh201538_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","volume":"358","author":"JA Staessen","year":"2001","unstructured":"Staessen JA, Wang J, Thijs L . Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358 (9290): 1305\u20131315.","journal-title":"Lancet"},{"issue":"15","key":"BFjhh201538_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370 (15): 1393\u20131401.","journal-title":"N Engl J Med"},{"key":"BFjhh201538_CR34","volume-title":"Rang & Dale\u2019s Pharmacology","author":"HP Rang","year":"2012","unstructured":"Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G . Rang & Dale\u2019s Pharmacology, 7th edn, Churchill Livingstone Edinburgh, 2012."},{"issue":"2","key":"BFjhh201538_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/jhh.2010.108","volume":"25","author":"J Bunker","year":"2011","unstructured":"Bunker J, Callister W, Chang CL, Sever PS . How common is true resistant hypertension? J Hum Hypertens 2011; 25 (2): 137\u2013140.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"BFjhh201538_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.113.01452","volume":"62","author":"FEM Fadl Elmula","year":"2013","unstructured":"Fadl Elmula FEM, Hoffmann P, Fossum E, Brekke M, Gj\u00f8nn\u00e6ss E, Hj\u00f8rnholm U et al. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Hypertension 2013; 62 (3): 526\u2013532.","journal-title":"Hypertension"},{"issue":"5","key":"BFjhh201538_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.114.03246","volume":"63","author":"FEM Fadl Elmula","year":"2014","unstructured":"Fadl Elmula FEM, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension 2014; 63 (5): 991\u2013999.","journal-title":"Hypertension"},{"issue":"11","key":"BFjhh201538_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","volume":"100","author":"M Tomaszewski","year":"2014","unstructured":"Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis. Heart 2014; 100 (11): 855\u2013861.","journal-title":"Heart"},{"issue":"1","key":"BFjhh201538_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/hr.2010.183","volume":"34","author":"J Ceral","year":"2011","unstructured":"Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M . Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertension Res 2011; 34 (1): 87\u201390.","journal-title":"Hypertension Res"},{"issue":"12","key":"BFjhh201538_CR40","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1097\/HJH.0b013e3283652c61","volume":"31","author":"B Strauch","year":"2013","unstructured":"Strauch B, Petrak O, Zelinka T, Rosa J, Somloova Z, Indra T et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens 2013; 31 (12): 2455\u20132461.","journal-title":"J Hypertens"},{"issue":"9","key":"BFjhh201538_CR41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS . Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. The Am J Med 2012; 125 (9): 882\u2013887.","journal-title":"The Am J Med"},{"issue":"7","key":"BFjhh201538_CR42","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archinte.1990.00390190043003","volume":"150","author":"AR Feinstein","year":"1990","unstructured":"Feinstein AR . On white-coat effects and the electronic monitoring of compliance. Arch Int Med 1990; 150 (7): 1377\u20131378.","journal-title":"Arch Int Med"},{"issue":"8","key":"BFjhh201538_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","volume":"63","author":"S Brinker","year":"2014","unstructured":"Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 2014; 63 (8): 834\u2013835.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"BFjhh201538_CR44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1097\/00004872-200410000-00002","volume":"22","author":"GE Wetzels","year":"2004","unstructured":"Wetzels GE, Nelemans P, Schouten JS, Prins MH . Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22 (10): 1849\u20131855.","journal-title":"J Hypertens"},{"issue":"2","key":"BFjhh201538_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.amjhyper.2006.07.018","volume":"20","author":"GEC Wetzels","year":"2007","unstructured":"Wetzels GEC, Nelemans PJ, Schouten JSAG, Dirksen CD, van der Weijden T, Stoffers HEJH et al. Electronic monitoring of adherence as a tool to improve blood pressure control*: a randomized controlled trial. Am J Hypertens 2007; 20 (2): 119\u2013125.","journal-title":"Am J Hypertens"},{"issue":"25","key":"BFjhh201538_CR46","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","volume":"126","author":"MD Esler","year":"2012","unstructured":"Esler MD, Krum H, Schlaich M, Schmieder RE, B\u00f6hm M, Sobotka PA . Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity htn-2 randomized, controlled trial. Circulation 2012; 126 (25): 2976\u20132982.","journal-title":"Circulation"},{"issue":"8","key":"BFjhh201538_CR47","doi-asserted-by":"publisher","first-page":"e002749","DOI":"10.1136\/bmjopen-2013-002749","volume":"3","author":"C Easthall","year":"2013","unstructured":"Easthall C, Song F, Bhattacharya D . A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open 2013; 3 (8): e002749.","journal-title":"BMJ Open"},{"issue":"6","key":"BFjhh201538_CR48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1751-7176.2011.00437.x","volume":"13","author":"MR Weir","year":"2011","unstructured":"Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ, Graff A, Shojaee A et al. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil\u00b1hydrochlorothiazide. J Clin Hypertens 2011; 13 (6): 404\u2013412.","journal-title":"J Clin Hypertens"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201538","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:57:53Z","timestamp":1691629073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,7]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFjhh201538"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2015.38","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,7]]},"assertion":[{"value":"31 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}